Artemis Medicare

{
  "main_header": {
    "sid": 1003372,
    "name": "Artemis Medicare",
    "stock_name": "Artemis Medicare",
    "full_name": "Artemis Medicare Services Ltd",
    "name_url": "stocks-analysis/artemis-medicare",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "265.35",
    "chg": -0.75,
    "chgp": "-0.28%",
    "dir": -1,
    "prev_price": "266.10",
    "mcapval": "4,149.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 542919,
    "symbol": "ARTEMISMED",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE025R01021",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "2.15 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/artemis-medicare-1003372-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Artemis Medicare Services Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-artemis-medicare-services-ltd-latest-results-good-or-bad-3983780",
        "imagepath": "",
        "date": "2026-05-09 19:18:02",
        "description": "Artemis Medicare Services Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹30.03 crores, reflecting a substantial quarter-on-quarter growth of 34.42% and a year-on-year increase of 30.40%. Revenue for the quarter reached ₹279.23 crores, which is a modest sequential growth of 2.53% and a more significant year-on-year rise of 16.39%. \n\nOperating margins showed notable fluctuations throughout the fiscal year, with Q4 margins at 18.48%, marking the highest level in seven quarters. This margin expansion was attributed to improved operating leverage and effective cost management, particularly in employee costs, which constituted 16.10% of sales. However, the volatility in operating margins throughout FY26—from 16.24% in Q1 to 18.42% in Q2, then down to 16.36% in Q3—raises questions about the sustainability of these profitability ..."
      },
      {
        "title": "Artemis Medicare Gains 6.42%: Technical Upgrades and Mixed Momentum Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artemis-medicare-gains-642-technical-upgrades-and-mixed-momentum-shape-week-3983090",
        "imagepath": "",
        "date": "2026-05-09 12:03:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.249.35</p>\n                    <p><strong>5 May:</strong> Stock upgraded to Hold on improved technicals and financials</p>\n                    <p><strong>6 May:</strong> Technical momentum shifts amid mixed market signals, stock closes at Rs.260.75 (+3.53%)</p>\n                    <p><strong>7 May:</strong> Mildly bullish momentum confirmed, stock rises to Rs.266.10 (+2.05%)</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.265.35 (-0.28%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.249.35</div></di..."
      },
      {
        "title": "Artemis Medicare Q4 FY26: Strong Profit Growth Masks Margin Volatility Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/artemis-medicare-q4-fy26-strong-profit-growth-masks-margin-volatility-concerns-3983127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ArtemisMedicare_quaterlyResult_3983127.png",
        "date": "2026-05-09 09:52:38",
        "description": "Artemis Medicare Services Ltd., the Gurugram-based multi-speciality hospital operator, reported a robust 30.40% year-on-year surge in consolidated net profit to ₹30.03 crores for Q4 FY26, marking its strongest quarterly performance to date. The ₹4,149 crore market capitalisation company delivered revenue of ₹279.23 crores for the March quarter, up 16.39% YoY, as patient volumes and average revenue per occupied bed continued their upward trajectory."
      },
      {
        "title": "Artemis Medicare Services Ltd Shows Mildly Bullish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artemis-medicare-services-ltd-shows-mildly-bullish-momentum-amid-technical-shifts-3980820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ArtemisMedicare_technicaldot_3980820.png",
        "date": "2026-05-08 08:05:09",
        "description": "Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for this small-cap hospital sector stock."
      },
      {
        "title": "Artemis Medicare Services Ltd Upgraded to Hold on Improved Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/artemis-medicare-services-ltd-upgraded-to-hold-on-improved-technicals-and-financials-3977154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ArtemisMedicare_mojoScore_3977154.png",
        "date": "2026-05-06 08:30:31",
        "description": "Artemis Medicare Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 5 May 2026, comes amid a backdrop of positive quarterly results, healthy debt servicing ability, and a stabilising technical outlook, signalling a cautious but optimistic stance for investors."
      },
      {
        "title": "Artemis Medicare Services Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artemis-medicare-services-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3976986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ArtemisMedicare_technicaldot_3976986.png",
        "date": "2026-05-06 08:06:10",
        "description": "Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors in the hospital sector."
      },
      {
        "title": "Artemis Medicare Services Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/artemis-medicare-services-ltd-is-rated-sell-3964172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArtemisMedicare_mojoScore_3964172.png",
        "date": "2026-04-27 10:10:52",
        "description": "Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Artemis Medicare Services Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artemis-medicare-services-ltd-technical-momentum-shifts-amid-mixed-market-signals-3958475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArtemisMedicare_technicaldot_3958475.png",
        "date": "2026-04-23 08:03:35",
        "description": "Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest 2.08% gain on 23 Apr 2026, the stock’s technical indicators reveal a cautious outlook, prompting a downgrade in its Mojo Grade from Hold to Sell as of 2 Mar 2026."
      },
      {
        "title": "Artemis Medicare Services Ltd Faces Bearish Technical Shift Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/artemis-medicare-services-ltd-faces-bearish-technical-shift-amid-market-challenges-3957125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArtemisMedicare_technicaldot_3957125.png",
        "date": "2026-04-22 08:04:29",
        "description": "Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has seen a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest price change on 22 Apr 2026, the stock’s technical indicators signal caution for investors amid a challenging market backdrop and underwhelming relative returns compared to the Sensex."
      }
    ],
    "total": 312,
    "sid": "1003372",
    "stock_news_url": "https://www.marketsmojo.com/news/artemis-medicare-services-1003372"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Board Meeting Held On May 8 2026",
      "datetime": "08-May-2026",
      "details": "Outcome of Board Meeting held on May 8 2026",
      "source": "BSE"
    },
    {
      "caption": "Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information",
      "datetime": "08-May-2026",
      "details": "Please find attached amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "08-May-2026",
      "details": "Earnings Presentation - Q4 FY26 and FY26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Artemis Medicare Services Ltd has declared <strong>45%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Artemis Medicare Services Ltd has announced <strong>1:10</strong> stock split, ex-date: 23 Sep 21",
          "dt": "2021-09-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Artemis Medicare Services Ltd latest results good or bad?

2026-05-09 19:18:02

Artemis Medicare Services Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹30.03 crores, reflecting a substantial quarter-on-quarter growth of 34.42% and a year-on-year increase of 30.40%. Revenue for the quarter reached ₹279.23 crores, which is a modest sequential growth of 2.53% and a more significant year-on-year rise of 16.39%. Operating margins showed notable fluctuations throughout the fiscal year, with Q4 margins at 18.48%, marking the highest level in seven quarters. This margin expansion was attributed to improved operating leverage and effective cost management, particularly in employee costs, which constituted 16.10% of sales. However, the volatility in operating margins throughout FY26—from 16.24% in Q1 to 18.42% in Q2, then down to 16.36% in Q3—raises questions about the sustainability of these profitability ...

Read full news article

Artemis Medicare Gains 6.42%: Technical Upgrades and Mixed Momentum Shape Week

2026-05-09 12:03:25

Key Events This Week

4 May: Week opens at Rs.249.35

5 May: Stock upgraded to Hold on improved technicals and financials

6 May: Technical momentum shifts amid mixed market signals, stock closes at Rs.260.75 (+3.53%)

7 May: Mildly bullish momentum confirmed, stock rises to Rs.266.10 (+2.05%)

8 May: Week closes at Rs.265.35 (-0.28%)

Week Open

Rs.249.35

Read full news article

Artemis Medicare Q4 FY26: Strong Profit Growth Masks Margin Volatility Concerns

2026-05-09 09:52:38

Artemis Medicare Services Ltd., the Gurugram-based multi-speciality hospital operator, reported a robust 30.40% year-on-year surge in consolidated net profit to ₹30.03 crores for Q4 FY26, marking its strongest quarterly performance to date. The ₹4,149 crore market capitalisation company delivered revenue of ₹279.23 crores for the March quarter, up 16.39% YoY, as patient volumes and average revenue per occupied bed continued their upward trajectory.

Read full news article

Artemis Medicare Services Ltd Shows Mildly Bullish Momentum Amid Technical Shifts

2026-05-08 08:05:09

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for this small-cap hospital sector stock.

Read full news article

Artemis Medicare Services Ltd Upgraded to Hold on Improved Technicals and Financials

2026-05-06 08:30:31

Artemis Medicare Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 5 May 2026, comes amid a backdrop of positive quarterly results, healthy debt servicing ability, and a stabilising technical outlook, signalling a cautious but optimistic stance for investors.

Read full news article

Artemis Medicare Services Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-05-06 08:06:10

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors in the hospital sector.

Read full news article

Artemis Medicare Services Ltd is Rated Sell

2026-04-27 10:10:52

Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Artemis Medicare Services Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-23 08:03:35

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest 2.08% gain on 23 Apr 2026, the stock’s technical indicators reveal a cautious outlook, prompting a downgrade in its Mojo Grade from Hold to Sell as of 2 Mar 2026.

Read full news article

Artemis Medicare Services Ltd Faces Bearish Technical Shift Amid Market Challenges

2026-04-22 08:04:29

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has seen a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest price change on 22 Apr 2026, the stock’s technical indicators signal caution for investors amid a challenging market backdrop and underwhelming relative returns compared to the Sensex.

Read full news article

View All News